PharmAust: Revenue Producing Biotech with Upcoming Phase 2 Trial

Mar. 16, 2016
PharmAust Limited (ASX: PAA) (“PharmAust,” or the “Company”) specializes in the relaunch of existing, established marketed products for oncology applications ...

 Read More

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market